Imax price target raised to $42 from $37 at Rosenblatt

Rosenblatt raised the firm’s price target on Imax (IMAX) to $42 from $37 and keeps a Buy rating on the shares. The firm says Imax remains its favorite name in the group, driven by continued box office strength in Q3. The company is positioned for another quarter of upside and the Q4 file slate is “chock-full of potential hits,” the analyst tells investors in a research note. Rosenblatt adds that Imax is trading well below the mid-teens multiple the stock has seen historically.